DOI: 10.12890/2022_003209

Invasive Pulmonary Aspergillosis after COVID-19 Pneumonia

Authors

  • Filipa David Internal Medicine Department, Hospital Pedro Hispano, Unidade Local de Saúde de Matosinhos, Portugal
  • Joana Rodrigues Morais Internal Medicine Department, Hospital Pedro Hispano, Unidade Local de Saúde de Matosinhos, Portugal
  • Francisca Beires Internal Medicine Department, Hospital Pedro Hispano, Unidade Local de Saúde de Matosinhos, Portugal
  • Helena Greefield Internal Medicine Department, Hospital Pedro Hispano, Unidade Local de Saúde de Matosinhos, Portugal
  • Gonçalo L Fernandes Intensive Care Unit, Hospital Pedro Hispano, Unidade Local de Saúde de Matosinhos, Portugal

filipa.dc@hotmail.com

Keywords

COVID-19, pulmonary aspergillosis, Aspergillus niger

Abstract

COVID-19 emerged in China in late 2019 and quickly spread worldwide. The severe immunomodulation and depletion of lymphocytes caused by the virus and its therapy led to an increase in the incidence of superinfections. COVID-19-associated pulmonary aspergillosis (CAPA) is a new entity with increasing incidence and high associated mortality.

We present the case of a 68-year-old patient admitted to our ward after recovering from severe COVID-19 pneumonia. Due to worsening of her clinical condition, chest computed tomography was performed and a lung abscess was documented with the identification of Aspergillus niger. Despite therapy with voriconazole, the patient’s condition deteriorated, culminating in her death.

COVID-19 emerged in China in late 2019 and quickly spread worldwide. The severe immunomodulation and depletion of lymphocytes caused by the virus and its therapy led to an increase in the incidence of superinfections. COVID-19-associated pulmonary aspergillosis (CAPA) is a new entity with increasing incidence and high associated mortality.

We present the case of a 68-year-old patient admitted to our ward after recovering from severe COVID-19 pneumonia. Due to worsening of her clinical condition, chest computed tomography was performed and a lung abscess was documented with the identification of Aspergillus niger. Despite therapy with voriconazole, the patient’s condition deteriorated, culminating in her death.

View the entire article

Downloads

References

  1. Machado M, Valerio M, Álvarez-Uría A, Olmedo M, Veintimilla C, Padilla B, et al. Invasive pulmonary aspergillosis in the COVID-19 era: an expected new entity. Mycoses 2021 Feb;64(2):132–143.
  2. Dewi IM, Janssen NA, Rosati D, Bruno M, Netea MG, Brüggemann RJ, et al. Invasive pulmonary aspergillosis associated with viral pneumonitis. Curr Opin Microbiol 2021 Aug;62:21–27.
  3. Lai C-C, Yu W-L. COVID-19 associated with pulmonary aspergillosis: a literature review. J Microbiol Immunol Infect 2021 Feb;54(1):46–53.
  4. El-Baba F, Gao Y, Soubani AO. Pulmonary aspergillosis: what the generalist needs to know. Am J Med 2020 Jun;133(6):668–674.
  5. Wauters J, Lamoth F, Rijnders BJ, Calandra T. Invasive pulmonary aspergillosis goes viral again? Am J Respir Crit Care Med 2021 Feb 1;203(3):275–277.

Published

2022-03-02

Issue

Vol. 9 No. 3 (2022)

Categories

How to Cite

1.
David F, Rodrigues Morais J, Beires F, Greefield H, Fernandes GL. Invasive Pulmonary Aspergillosis after COVID-19 Pneumonia. EJCRIM [Internet]. 2022 Mar. 2 [cited 2026 Nov. 3];9(3). Available from: https://ejcrim.com/index.php/ejcrim/article/view/3209

Most read articles by the same author(s)